Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 3398-3406, July 1, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodriguez, E.
Right arrow Articles by Chaganti, R. S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez, E.
Right arrow Articles by Chaganti, R. S. K.

Genetic Changes in Epithelial Solid Neoplasia1

Eduardo Rodriguez, Chandrika Sreekantaiah and R. S. K. Chaganti2

Cell Biology and Genetics Program and the Cytogenetics Service, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021

Although chromosomal analysis of solid epithelial neoplasms has lagged behind that of hematopoietic, mesenchymal, and germ cell tumors, gradual accumulation of data over the past 5 years enables development of a general view. Thus, these tumors appear to be characterized by a set of nonrandom deletions the incidence of which varies in tumors of different histological types. Most tumors were studied at advanced stages; therefore, essentially no data are available on the cytogenetic characteristics of the earliest stages of tumorigenesis. In contrast to the status of cytogenetic data, a large body of information on deletions at the molecular level assayed by the loss of heterozygosity analysis has accumulated over the same period. These data have been less complete than the cytogenetic data, although in cases such as colorectal carcinoma, genetic changes from the earliest to the most advanced stages have been studied in detail providing a genetic view of progression. Equally important is the fact that deletion mapping studies by the loss of heterozygosity assay directly lead to isolation of a number of tumor suppressor genes. A comparison of the pattern of deletions identified by chromosomal and loss of heterozygosity analysis revealed, as expected, a concordance. Comparison of the patterns of chromosomal (and the underlying molecular) changes in tumors between major embryological cell types demonstrates fundamental differences in genetic mechanisms which lead to tumorigenesis.

1 Supported in part by NIH Grants CA-05826 and CA-08748.

2 To whom requests for reprints should be addressed, at Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021.

Received 2/22/94. Accepted 4/24/94.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Rubin
Degrees and kinds of selection in spontaneous neoplastic transformation: An operational analysis
PNAS, June 28, 2005; 102(26): 9276 - 9281.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
K M Rieger-Christ, J A Pezza, J M Dugan, J W Braasch, K S Hughes, and I C Summerhayes
Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas
Mol. Pathol., April 1, 2001; 54(2): 91 - 97.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
H. Rubin
Selected Cell and Selective Microenvironment in Neoplastic Development
Cancer Res., February 1, 2001; 61(3): 799 - 807.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. Chow and H. Rubin
Clonal Selection versus Genetic Instability as the Driving Force in Neoplastic Transformation
Cancer Res., November 1, 2000; 60(22): 6510 - 6518.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
J. Yokota
Tumor progression and metastasis
Carcinogenesis, March 1, 2000; 21(3): 497 - 503.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. P. Basilion, A. R. Schievella, E. Burns, P. Rioux, J. C. Olson, B. P. Monia, K. M. Lemonidis, V. P. Stanton Jr., and D. E. Housman
Selective Killing of Cancer Cells Based on Loss of Heterozygosity and Normal Variation in the Human Genome: A New Paradigm for Anticancer Drug Therapy
Mol. Pharmacol., August 1, 1999; 56(2): 359 - 369.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Chow and H. Rubin
Clonal dynamics of progressive neoplastic transformation
PNAS, June 8, 1999; 96(12): 6976 - 6981.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Chow and H. Rubin
The cellular ecology of progressive neoplastic transformation: A clonal analysis
PNAS, March 2, 1999; 96(5): 2093 - 2098.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Peng, A. Genin, N. B. Spinner, R. H. Diamond, and R. Taub
The Gene Encoding Human Nuclear Protein Tyrosine Phosphatase, PRL-1. CLONING, CHROMOSOMAL LOCALIZATION, AND IDENTIFICATION OF AN INTRON ENHANCER
J. Biol. Chem., July 3, 1998; 273(27): 17286 - 17295.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.